Search results
May 9, 2024 · Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and ...
Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Apr 11, 2024 · We believe that biology is the best manufacturing technology on the planet. But engineering living cells is hard–evolution is four billion years ahead of us, after all. At Ginkgo we’ve built our foundries and codebase so that we can better learn from and design with biology.
May 8, 2023 · BOSTON, May 8, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership with Boehringer ...
Apr 11, 2024 · Ginkgo is your end-to-end synthetic biology R&D partner. Browse a selection of our partner projects and case studies to explore how biology is being used across industries. Speak to our team today to access more.
Sep 14, 2021 · Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds. Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021. Ginkgo Set to Begin Trading under NYSE: DNA ...
Apr 11, 2024 · From small molecule discovery and manufacturing to biologics, cell and gene therapy, RNA therapeutics and vaccines, and beyond, Ginkgo is your cell engineering partner. Our services enable discovery, optimization, and scale up for a wide range of therapeutics modalities.
